COVID-19-related vaccines and therapeutics : Preliminary insights on related patenting activity during the pandemic / World Intellectual Property Organization Staff.

Format:

Book

Author/Creator:

World Intellectual Property Organization Staff, author.

Language:

English

Subjects (All):

COVID-19 (Disease).

Physical Description:

1 online resource (83 pages)

Edition:

First edition.

Place of Publication:

Geneva, Switzerland : World Intellectual Property Organization (WIPO), [2022]

Summary:

Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus and the related disease. This patent landscape report provides early observations on the patenting activity which took place in the field of COVID-19 vaccines and therapeutics, and compares results with clinical trial data for related candidate vaccines and drugs.

Contents:

Intro

_Hlk93048502

Acknowledgements

Key findings

Introduction

Background - biology of COVID-19

Overview of patenting activity related to COVID-19

Patent filings during 2020-2021

Filing and publication of COVID-19-related patent applications over time

COVID-19-related vaccine and therapeutic patent applicant profiles

Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics

Disclosure of sequences within patent documents

COVID-19 vaccines

Background - vaccine platforms

Conventional vaccine platforms

Novel vaccine platforms

Patent and vaccine distribution by vaccine platform and published applicant location

Speed of vaccine development

COVID-19 vaccine patent landscape

Core vaccine technologies, collaboration and licensing

Analysis of WHO data on COVID-19 vaccines

Timelines on key technologies for COVID-19 vaccine development

Technologies relevant to mRNA vaccine

Timeline details for adenovirus vaccine development

Timeline details for vaccine adjuvant development

COVID-19 therapeutics

Background

Analysis of COVID-19 therapeutics-related patent applications by substances type

Top locations of patent applicants for COVID-19 therapeutics and their filing strategies

Highlights of patent filings related to COVID-19 therapeutic development

Patent filings related to development of small-molecule drugs for COVID-19

Patent filings related to the development of biologics for COVID-19

Patents related to antibodies for COVID-19 treatment

Peptide and protein therapies

Nucleic-acid-based therapies

Aptamer-mediated therapy

Cell-based therapies

Other biologic-based therapies

Analysis of COVID-19 therapeutics in clinical trials.

Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data

Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs

Classification of COVID-19 drug candidates in clinical trials by molecular nature and function

Feature summary of examples of anti-COVID-19 drug candidates in clinical trials

Perspectives

Annex

Data sources and methods

Tables of vaccine types and candidates currently in clinical trials

Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices

Glossary

References

Further reading.

Notes:

Includes bibliographical references.

Description based on publisher supplied metadata and other sources.

Description based on print version record.

Other Format:

Print version: Staff, World Intellectual Property Organization COVID-19-related vaccines and therapeutics

ISBN:

9789280533606

OCLC:

1348480949